Form 4 for TNGX Tango Therapeutics, Inc.
Accepted 2024-11-18 00:00:00 ET · period of report 2024-11-14 · accession 0000950170-24-128163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-18 | 2024-11-14+ | TNGX | Rothenberg Mace | Dir | P - Purchase | $3.70 | +20.0K | 21.2K | +1,600% | +$74.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | P | A | 10,000 | $3.78 | 31,250 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-14 | P | A | 10,000 | $3.62 | 21,250 | D | — | — |